Taxoplasmosis Encephalitis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
- Transparency Market Research
Taxoplasmosis encephalitis is an infection caused by Taxoplasma gondii, an intracellular protozoan parasite. The infection can occur pre-natally or post-natally. It may be caused by exposure or consumption of undercooked meat, drinking of unpasteurized goat milk, contact with soil, cleaning of cat litter boxes, and ingestion of unwashed raw fruits or vegetables. The infection can also occur during organ transplantation or due to laboratory accidents. Prevalence of the infection varies from country to country. The prevalence is high in Latin America and countries of tropical Africa. North America, Southeast Asia, Northern Europe, and Africa witness low sero-prevalence, while Central and Southern Europe witness moderate prevalence of the disease.
The global taxoplasmosis encephalitis market can be segmented based on diagnostic tests and geography. Diagnostic tests include serological investigations, direct detection, and imaging. Presence of IgG antibodies indicates risk of infection. Monitoring of IgM and IgA levels in neonates helps in screening of the infection. Imaging tests comprise MRI or CT scanning for brain lesions. Newer scanning procedures viz. PET or SPECT imaging assist in distinguishing taxoplasma encephalitis from other infections of the central nervous system. Fetal or neonatal ultrasonography can be performed in cases of known transplacental infection. Positron emission tomography (PET) or single-photon emission computed tomography (SPECT) scanning can be helpful in distinguishing between taxoplasmosis encephalitis and primary central nervous system (CNS) lymphoma. However, no imaging technique is completely specific.
Polymerase chain reaction (PCR) amplification technique, screening of tissue sections or body smears, and tests such as tissue culture or biopsy stain are some of the direct tests for detecting the presence of Taxoplasma gondii. Tissue section and body smearing tests are conducted to find out the presence of tachyzoites, which is an active form of the parasite. Polymerase chain reactions allow detection of presence of the parasite in the blood, the body tissues, and the fluids. This test particularly helps in the diagnosis of disseminated disease, especially in HIV patients and intrauterine toxoplasmosis patients. Individuals infected with HIV should be tested for IgG antibody against the organism to detect the latent infection of T. gondii.
Patients with taxoplasmosis encephalitis are administered anticonvulsants if they have past history of seizures. However, it is not recommended as prophylaxis for all patients. Other drugs which may be administered to treat the infection are pyrimethamine, sulfonamides, spiramycinm clindamycin, macrolides, hydroxynaphtoquinones, folate inhibitors, immunomodulators, and other combination drugs. Geographically, the global taxoplasmosis encephalitis market can be categorized into four major regions viz. North America, Europe, Asia Pacific, and Rest of World. In the U.S., toxoplasmic encephalitis is mostly caused by reactivation of chronic infection in patients with HIV. Moreover, the incidence of this disease has a direct correlation with the presence of antibodies against T. gondii. Approximately 10% to 40% of patients with HIV in the U.S. manifest presence of antibodies against T. gondii.
Various studies indicate that 50% of T. gondii-seropositive AIDS patients develop toxoplasmic encephalitis in a due course of time. The risk of toxoplasmosis decreases after administration of a primary prophylaxis against T. gondii and recommendation of effective therapy against the retrovirus. Prevalence of the asymptomatic infection usually increases with the age. Seroprevalence rates of this parasitic infection have been declining worldwide. However, it is observed to be high in South America, Africa, and Europe. Furthermore, in some of these places, rates may be still increasing. Some of the key players operating in the global taxoplasmosis encephalitis market include DiaSorin, Glenmark, GlaxoSmithKline, Hoffman La Roche, and Boehringer Ingelheim.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Pharmaceutical
PharmaceuticalChinese Markets for Mental Illness Drugs
PharmaceuticalChinese Markets for Anti-Dermatomycosis Skin Drugs
PharmaceuticalChinese Markets for Incretion Drugs
PharmaceuticalChinese Markets for Hypertension Drugs
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017